Integral Health Asset Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-100,000
| Closed | -$5.06M | – | 68 |
|
|
2023
Q3 | $5.06M | Buy |
100,000
+30,000
| +43% | +$1.52M | 0.7% | 49 |
|
|
2023
Q2 | $3.27M | Hold |
70,000
| – | – | 0.4% | 63 |
|
|
2023
Q1 | $2.68M | Hold |
70,000
| – | – | 0.54% | 55 |
|
|
2022
Q4 | $3.84M | Sell |
70,000
-160,000
| -70% | -$8.77M | 0.81% | 42 |
|
|
2022
Q3 | $7.83M | Sell |
230,000
-58,058
| -20% | -$1.98M | 1.52% | 25 |
|
|
2022
Q2 | $2.72M | Buy |
288,058
+88,058
| +44% | +$832K | 0.56% | 53 |
|
|
2022
Q1 | $2.84M | Buy |
200,000
+115,000
| +135% | +$1.63M | 0.74% | 48 |
|
|
2021
Q4 | $1.8M | Hold |
85,000
| – | – | 0.5% | 55 |
|
|
2021
Q3 | $1.9M | Hold |
85,000
| – | – | 0.55% | 55 |
|
|
2021
Q2 | $2.11M | Hold |
85,000
| – | – | 0.58% | 50 |
|
|
2021
Q1 | $2.47M | Hold |
85,000
| – | – | 0.7% | 47 |
|
|
2020
Q4 | $2.19M | Hold |
85,000
| – | – | 0.65% | 44 |
|
|
2020
Q3 | $2.62M | Buy |
+85,000
| New | +$2.62M | 0.8% | 44 |
|
|
2020
Q2 | – | Sell |
-60,000
| Closed | -$1.27M | – | 59 |
|
|
2020
Q1 | $1.27M | Buy |
+60,000
| New | +$1.27M | 0.56% | 47 |
|